The Robert Bosch Center for Tumor Diseases (RBCT) is a new translational cancer research institute located on the Bosch Health Campus in Stuttgart, Germany. We are closely linked to the Robert Bosch Hospital (RBK) and the Institute for Clinical Pharmacology (IKP) and are part of the Comprehensive Cancer Center Stuttgart-Tübingen.
Our mission is to explore the molecular mechanisms that drive tumor growth and metastasis, with the goal of improving cancer patient treatment. Our research focuses on cellular identity regulation through transcriptional and epigenetic mechanisms, using high-throughput omics data.
Robert-Bosch-Krankenhaus GmbH